Immune-mediated vascular leakage in hantavirus pathogenesis

Description of the granted funding

Hantaviruses pose a significant threat to human health by causing Hemorrhagic Fever with Renal Syndrome (HFRS, mortality 0,1-5% ) in Eurasia and Hantavirus Cardiopulmonary Syndrome (HCPS, mortality 40%) in the Americas. Similarly to other hemorrhagic fever-causing viruses, the pathogenesis of HFRS and HCPS is thought to occur through increased vascular leakage. I aim to elucidate the role of overt immune cell activation in the pathogenesis of hantavirus diseases by using patient samples from Puumala hantavirus-caused HFRS in Finland and Andes hantavirus-caused HCPS in Argentina. To analyze cause and effect relationships, sophisticated experimental infection setups will be also employed. The outcome of this research is an increased understanding of the pathological mechanisms of hantavirus diseases which can be applicable also to other virus-caused hemorrhagic fevers and will facilitate the development of novel therapeutic strategies towards these devastating diseases.
Show more

Starting year

2019

End year

2024

Granted funding

Tomas Strandin Orcid -palvelun logo
438 874 €

Related funding decisions

353153
Research costs of Academy Research Fellows(2022)
200 000 €
328807
Research costs of Academy Research Fellows(2019)
300 000 €

Funder

Research Council of Finland

Funding instrument

Academy research fellows

Other information

Funding decision number

321809

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

covid, pandemic, vaccines